Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides

Vaccine

Volumn 25, Issue 6, 2007, Pages 1007-1013

  Inoue, Joe ^a   Aramaki, Yukihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

CpG ODN; Tape stripping; Th1; TLR 9; Transdermal vaccination

Indexed keywords

ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OVALBUMIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFECT; GENE EXPRESSION; LYMPH NODE; LYMPHATIC DRAINAGE; MALE; MOUSE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIGEN-PRESENTING CELLS; MALE; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; RNA, MESSENGER; SKIN; TH1 CELLS; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 33845581291     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.075     Document Type: Article

References (28)

1. Seo N., Tokura Y., Nishijima T., Hashizume H., Furukawa F., and Takigawa M. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci USA 97 (2000) 371-376
2. Takigawa M., Tokura Y., Hashizume H., Yagi H., and Seo N. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Ann NY Acad Sci 941 (2001) 139-146
3. Bins A.D., Jorritsma A., Wolkers M.C., Hung C.F., Wu T.C., Schumacher T.N., et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11 (2005) 899-904
4. Kahlon R., Hu Y., Orteu C.H., Kifayet A., Trudeau J.D., Tan R., et al. Optimization of epicutaneous immunization for the induction of CTL. Vaccine 20 21 (2003) 2890-2899
5. Klimuk S.K., Najar H.M., Semple S.C., Aslanian S., and Dutz J.P. Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J Invest Dermatol 122 (2004) 1042-1049
6. Beignon A.S., Briand J.P., Muller S., and Partidos C.D. Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells. Immunology 105 (2002) 204-212
7. Zhao Y.L., Murthy S.N., Manjili M.H., Guan L.J., Sen A., and Hui S.W. Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 27 (2005) [Epub ahead of print]
8. Kendall M. Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine 12 (2005) [Epub ahead of print]
9. Strid J., Hourihane J., Kimber I., Callard R., and Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 34 (2004) 2100-2109
10. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20 (2002) 709-760
11. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
12. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
13. Wagner H. Toll meets bacterial CpG-DNA. Immunity 14 (2001) 499-502
14. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., and Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993) 547-549
15. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14 (1993) 335-338
16. Klinman D.M., Currie D., Gursel I., and Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199 (2004) 201-216
17. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
18. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170 (1989) 2081-2095
19. Yu P., Spiotto M.T., Lee Y., Schreiber H., and Fu Y.X. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med 197 (2003) 985-995
20. Giuntoli II R.L., Lu J., Kobayashi H., Kennedy R., and Celis E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin Cancer Res 8 (2002) 922-931
21. Liu L., Zhou X., Shi J., Xie X., and Yuan Z. Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin. Immunology 110 (2003) 341-347
22. Inoue J., Yotsumoto S., Sakamoto T., Tsuchiya S., and Aramaki Y. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. J Contr Rel 108 (2005) 294-305
23. Inoue J., Yotsumoto S., Sakamoto T., Tsuchiya S., and Aramaki Y. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice. Pharm Res 22 (2005) 1627-1633
24. Wang B., Zhuang L., Fujisawa H., Shinder G.A., Feliciani C., Shivji G.M., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 162 (1999) 277-283
25. Fukunaga A., Nagai H., Noguchi T., Okazawa H., Matozaki T., Yu X., et al. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J Immunol 172 (2004) 4091-4099
26. Holzmann S., Tripp C.H., Schmuth M., Janke K., Koch F., Saeland S., et al. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 122 (2004) 1165-1174
27. Miller L.S., Sorensen O.E., Liu P.T., Jalian H.R., Eshtiaghpour D., Behmanesh B.E., et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 174 (2005) 6137-6143
28. Nickoloff B.J., and Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30 (1994) 535-546